Oct. 16, 2018
News

Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec

Miltenyi Biotec GmbH, a global provider of products and services for advancing biomedical research and cellular therapy, announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH.

Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its foundation in 2000, LaVision BioTec has developed innovative products that successfully address the high-end microscopy market for applications in neuroscience, oncology, immunology, and developmental biology. TriM Scope is the company’s modular multiphoton and confocal microscopy platform that combines single- and multi-beam operation and enables simultaneous real-time and deep in vivo imaging. With its UltraMicroscopes, LaVision BioTec launched the first commercial light-sheet microscopes, allowing imaging of large cleared tissue samples.

“We are very happy to welcome our new colleagues from LaVision BioTec to our organization”, says Stefan Miltenyi, founder of Miltenyi Biotec. “By combining our expertise in cell analysis and innovative detection reagents with LaVision BioTec’s imaging know-how, we will develop pioneering analytical tools for biomedical research.”

“Our mission has always been to develop and market new technologies such as multiphoton-microscopy and light-sheet microscopy”, explains Dr. Heinrich Spiecker, Managing Director of LaVision BioTec. “By joining Miltenyi Biotec we have fused with a partner that will drive our business forward and increase the range of applications for our systems.”

LaVision BioTec will become part of the Miltenyi Biotec family, and will continue operating from their headquarters in Bielefeld. Miltenyi Biotec will market LaVision BioTec’s products.

Further information:

Milteny Biotec

LaVision Biotec
 

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.